IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform

About this update from Iqvia Holdings, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":546,"height":209,"url":"https://media.zenfs.com/en/business-wire.com/1af544c5985feb2f6c0c0188792d3b9e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/e2aSCT1871S6BWMGea.TEQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTM2NztjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/1af544c5985feb2f6c0c0188792d3b9e","width":546,"height":209}},"lazy":false},{"type":"text","content":"RESEARCH TRIANGLE PARK, N.C., December 02, 2025--(BUSINESS WIRE)--IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced a strategic collaboration with Amazon Web Services (AWS), naming AWS as IQVIA’s Preferred Agentic Cloud Provider. The partnership, revealed at AWS re:Invent, is a major step in the digital transformation of healthcare and life sciences, aiming to revolutionize clinical trial automation, medical affairs and analytics through an innovative agentic AI platform.","length":614,"tagName":"p"},{"type":"text","content":"Under the agreement, IQVIA will deploy its AI platform on AWS to enhance scalable, secure and intelligent automation across clinical trial execution, medical affairs and healthcare analytics. This collaboration is designed to improve clinical trial automation and accelerate trial processes. In addition, IQVIA and AWS will explore new opportunities in life science analytics to drive the next generation of data-driven insights and solutions.","length":443,"tagName":"p"},{"type":"text","content":"With 90% of the world’s largest pharmaceutical companies relying on both IQVIA and AWS to power their digital transformation and analytics, the companies are committed to democratizing AI for life sciences, accelerating drug innovation and enabling the faster delivery of life-saving treatments to patients around the globe.","length":324,"tagName":"p"},{"type":"text","content":""We are excited to move forward with AWS as IQVIA’s Preferred Agentic Cloud Provider. Our AI platform aims to empower life sciences organizations to innovate faster and deliver treatments to patients more efficiently," said Lucas Glass, SVP, Architecture and Standards at IQVIA. "With agentic AI, we ...

More updates from Iqvia Holdings, Inc.